NOVA Biomedical Switzerland GmbH

Advanced Instruments has merged with Nova Biomedical and we are excited to share our larger portfolio with you at Cell & Gene Meeting on the Mesa. Artel®, Solentim®, BioProfile®, and the OsmoTECH® portfolio together form a comprehensive suite of advanced analytical and automation solutions designed to accelerate bioprocessing and cell line development workflows. From ensuring liquid handling accuracy with Artel®, to enabling single cell cloning and imaging with Solentim®, to delivering real time bioprocess analytics through BioProfile® and precise osmolality measurement with OsmoTECH®, the portfolio supports critical decisions from early development through manufacturing. Together, these technologies help biopharma teams improve data integrity, increase efficiency, and confidently advance complex biologics to market.